Rachel Wightman, MD is an Assistant Professor of Emergency Medicine at Alpert Medical School of Brown University. She is triple board-certified in medical toxicology, emergency medicine, and addiction medicine. She serves as the Director of Medical Toxicology Education for Brown Emergency Medicine and also as faculty in the addiction medicine fellowship at Rhode Island Hospital.
Her research interests are emerging drug use patterns, evaluation of toxicology testing results, and medication management of opioid use disorder. She co-founded the Rhode Island Buprenorphine Hotline, a statewide telehealth low-threshold buprenorphine treatment access line in partnership with RIDOH funded by SAMSHA. She is an invited member of the Rhode Island Review of Overdose Accidental Deaths (ROAD) committee.
Dr. Wightman is currently PI on a NIDA funded R21 investigating
cannabis hyperemesis (R21DA055023) and a RI COBRE on Opioid and Overdose Project Lead (P20GM125507). She is MPI on a FORE Foundation funded study evaluating the local drug supply and a NIDA study evaluating optimal buprenorphine maintenance dose for MOUD in patients with fentanyl use (UG3DA056880). She also serves as the medical toxicology consultant for the Massachusetts Drug Supply Data Stream (MADDS), a collaborative project between Brandeis researchers and the Massachusetts Department of Public Health, dedicated to learn more about the local illicit drug supply to better inform public health and public safety responses. She serves on the Medical Executive Committee at The Miriam Hospital and the Office of Women in Medicine and Science Advisory Board at Alpert Medical School of Brown University.